It is currently Tue May 24, 2016 4:32 pm
Biogen reported the first case of progressive multifocal leukoencephalopathy (PML) in a Tecfidera patient, who had been part of a clinical trial and was taking the drug for 4-1/2 years.
The patient, who died of pneumonia, had been suffering severe lymphopenia, a low white blood cell condition, for more than three years, which Biogen said was a risk factor for developing PML.
Biogen, which ...
Total posts 232435 • Total topics 24847 • Total members 16005